Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Vertistop

Approved

STANDARD

Vertistop

Windlas Biotech Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 0d58c652b23a4b21
Company: Windlas Biotech Limited
Type: Standard

Approval Details

Approval Id: 0d58c652b23a4b21
Drug Approval Philippines Name: Vertistop
Product Name: Vertistop
Registration Number: DRP-5646-01
Brand Name: Vertistop
Generic Name: Betahistine Hydrochloride
Dosage Form: Tablet
Dosage Strength: 8 mg
Manufacturer: Windlas Biotech Limited
Importer: Ambica International Trading Corp.
Distributor: Medchoice Pharma, Inc.
Company Detail Path: /organization/windlas-biotech-limited
Issuance Date: 01 May 2024
Expiry Date: 08 January 2030
Pharmacologic Category: Antivertigo
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0d58c652b23a4b21

Type

Standard

Back to Philippines FDA Approvals

Vertistop - Philippines FDA Drug Approval Details